MIR6770-1

Across TCGA pan-cancer cohorts, MIR6770-1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR6770-1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR6770-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6770-1 expression acts as an unfavorable survival marker.

BLCA, LIHC, and OV are the cancer types where MIR6770-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.085	0.720	<.001	144	view →
LIHC	OS	Tertile	All	0.092	0.783	<.001	81	view →
OV	OS	Tertile	II,III,IV	0.272	0.693	.002	54	view →
LUSC	OS	Tertile	All	0.165	0.675	.019	36	view →
ESCA	OS	Tertile	II,III,IV	0.345	0.686	.047	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR6770-1–BLCA (OS)

Open the BLCA breakdown →